Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCroda International Regulatory News (CRDA)

Share Price Information for Croda International (CRDA)

Share Price is delayed by 15 minutes
Get Live Data
2,949.00    -78.00 (-2.58%)
Bid:
2,942.00
Ask:
2,946.00
Spread: 4.00 (0.136%)
Market Cap: £4.11b
CRDA Live PriceLast checked at - London Stock Exchange

Intraday Croda International Share Chart

Directorate Change

24 Mar 2023 10:31

RNS Number : 1733U
Croda International PLC
24 March 2023
 

24 March 2023

 

Croda International Plc

 

 

Appointment of Non-Executive Director

 

The Board of Croda International Plc is pleased to announce the appointment of Chris Good as non-executive director. Chris will join the Board with effect from 27 April 2023.

 

Chris has spent his career in the consumer care industry. He recently retired following more than 20 years at Estee Lauder Companies, a global leader in prestige beauty, with the last five years of his executive career as Group President of North America (Estee Lauder Companies' home market) with responsibility for over 25 brands. Chris was also a member of Estee Lauder Companies' Executive Committee.

 

Prior to joining Estee Lauder Companies, Chris spent over 10 years at Unilever in senior marketing, executive and general management roles across Europe, North America and Asia.

 

On joining the Croda Board, Chris will also be appointed to the Audit, Nomination and Remuneration Committees. 

 

Anita Frew, Chair of Croda International Plc, said,

 

"I am delighted to welcome Chris to the Croda Board.

 

Chris' deep understanding of the consumer care industry and in particular his insights into beauty care markets and consumers will be of great value to Croda and the Board. As well as having significant P&L experience, Chris also brings a truly international perspective to the Board, having lived and worked in the USA, Switzerland, Japan, Singapore, Russia and the UK with region wide responsibilities for EMEA, APAC and North America during his successful executive career.

 

His appointment strengthens the consumer care knowledge and experience we have around the Board table, which will support our continued transition to a pure play Consumer Care and Life Sciences business."

 

There are no further matters to be disclosed under LR9.6.13R of the Listing Rules of the UK Listing Authority.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAFZGZFGDGGFZM
Date   Source Headline
21st Dec 201011:39 amRNSDirector/PDMR Shareholding
13th Dec 20104:39 pmRNSDirector/PDMR Shareholding
7th Dec 20105:24 pmRNSDirector/PDMR Shareholding
11th Nov 20105:14 pmRNSDirector/PDMR Shareholding
2nd Nov 201010:27 amRNSDirector/PDMR Shareholding
28th Oct 201010:24 amRNSHolding(s) in Company
28th Oct 20107:00 amRNSQ3 Trading Statement
13th Oct 20105:20 pmRNSDirector/PDMR Shareholding
7th Oct 20104:39 pmRNSDirector/PDMR Shareholding
22nd Sep 20103:26 pmRNSDirector/PDMR Shareholding
17th Sep 20109:50 amRNSDirector/PDMR Shareholding
13th Sep 20102:56 pmRNSDirector/PDMR Shareholding
9th Sep 20107:00 amRNSSite Visit
12th Aug 201011:25 amRNSDirector/PDMR Shareholding
28th Jul 20104:29 pmRNSHolding(s) in Company
27th Jul 20107:00 amRNSInterim Results
15th Jul 201011:29 amRNSHolding(s) in Company
13th Jul 20103:32 pmRNSDirector/PDMR Shareholding
1st Jul 20107:00 amRNSBoard Appointments
1st Jul 20107:00 amRNSCompletion of Sale
14th Jun 20104:35 pmRNSDirector/PDMR Shareholding
8th Jun 201012:15 pmRNSDirector/PDMR Shareholding
20th May 20104:37 pmRNSDirector/PDMR Shareholding
11th May 20102:39 pmRNSDirector/PDMR Shareholding
10th May 20107:00 amRNSSale of German Oleochemicals Business
7th May 20103:35 pmRNSHolding(s) in Company
30th Apr 20103:10 pmRNSDirector/PDMR Shareholding
30th Apr 201011:54 amRNSHolding(s) in Company
28th Apr 20105:04 pmRNSResult of AGM
28th Apr 20107:00 amRNSQ1 2010 Trading Statement
13th Apr 20104:57 pmRNSDirector/PDMR Shareholding
8th Apr 20102:08 pmRNSAnnual Information Update
29th Mar 20104:53 pmRNSDirector/PDMR Shareholding
25th Mar 20105:03 pmRNSHolding(s) in Company
25th Mar 20102:15 pmRNSAnnual Financial Report
23rd Mar 20105:03 pmRNSDirector/PDMR Shareholding
17th Mar 20101:39 pmRNSDirector/PDMR Shareholding
11th Mar 20104:34 pmRNSDirector/PDMR Shareholding
9th Mar 20104:52 pmRNSDirector/PDMR Shareholding
5th Mar 20102:08 pmRNSTotal Voting Rights
5th Mar 20102:07 pmRNSTransaction in Own Shares
2nd Mar 201012:20 pmRNSDirector/PDMR Shareholding
25th Feb 20104:18 pmRNSDirector/PDMR Shareholding
24th Feb 20104:22 pmRNSDirector/PDMR Shareholding
23rd Feb 20107:00 amRNSFinal Results
11th Feb 20102:51 pmRNSDirector/PDMR Shareholding
13th Jan 20109:07 amRNSDirector/PDMR Shareholding
11th Dec 20094:02 pmRNSDirector/PDMR Shareholding
1st Dec 200912:13 pmRNSDirector/PDMR Shareholding
11th Nov 20094:30 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.